KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

CRISPR Therapeutics AG (CRSP) Return on Invested Capital (2019 - 2023)

Historic Return on Invested Capital for CRISPR Therapeutics AG (CRSP) over the last 10 years, with Q3 2025 value amounting to 0.32%.

  • CRISPR Therapeutics AG's Return on Invested Capital fell 1500.0% to 0.32% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.32%, marking a year-over-year decrease of 1500.0%. This contributed to the annual value of 0.25% for FY2024, which is 1300.0% down from last year.
  • Per CRISPR Therapeutics AG's latest filing, its Return on Invested Capital stood at 0.32% for Q3 2025, which was down 1500.0% from 0.31% recorded in Q2 2025.
  • In the past 5 years, CRISPR Therapeutics AG's Return on Invested Capital ranged from a high of 0.2% in Q2 2021 and a low of 0.35% during Q4 2022
  • For the 5-year period, CRISPR Therapeutics AG's Return on Invested Capital averaged around 0.16%, with its median value being 0.24% (2023).
  • In the last 5 years, CRISPR Therapeutics AG's Return on Invested Capital soared by 3900bps in 2021 and then plummeted by -5000bps in 2022.
  • CRISPR Therapeutics AG's Return on Invested Capital (Quarter) stood at 0.15% in 2021, then plummeted by -333bps to 0.35% in 2022, then surged by 64bps to 0.13% in 2023, then tumbled by -94bps to 0.24% in 2024, then plummeted by -31bps to 0.32% in 2025.
  • Its last three reported values are 0.32% in Q3 2025, 0.31% for Q2 2025, and 0.25% during Q1 2025.